ReSync
San Francisco, CA, United States
ReSync Bio is a scientific software company that provides a cloud-based platform to streamline preclinical operations for biopharma companies, accelerating therapeutic development.
How We Help
Problem Statement
Addresses bottlenecks in preclinical drug discovery caused by disconnected software tools, disorganized data, and challenges coordinating programs across in-house labs and contract research organizations (CROs).
Core Technology
Scientific software platform
Key Differentiators
Plug-and-play tool for automating coordination between drug discovery teams and labs, organizes and trains data, models, and experimental workflows, bridges in silico design and lab execution, provides no-code access to advanced AI tools.
Clinical Focus
Preclinical Research
Target Customers
Biopharma companies
Product Stage
GA
Company Info
- Business Model
- SaaS
- Founded
- 2024
- Website
- resync.bio/
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Focus is preclinical; no clinical validation mentioned.
MedStartr Index Score
?What do you think of ReSync?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.